首页> 外文期刊>Gastroenterology research and practice >Predictive Factors of Early Recurrence in Patients with Distal Cholangiocarcinoma after Pancreaticoduodenectomy
【24h】

Predictive Factors of Early Recurrence in Patients with Distal Cholangiocarcinoma after Pancreaticoduodenectomy

机译:胰腺癌后远端胆管癌患者早期复发预测因素

获取原文
获取原文并翻译 | 示例
           

摘要

Aim. To determine the factors associated with early recurrence in patients with distal cholangiocarcinoma after pancreaticoduodenectomy (PD). Patients and Methods. Sixty-one patients with distal cholangiocarcinoma were enrolled. The clinical data and histopathological findings were collected retrospectively. Results. Patients were divided into two groups as follows: 16 patients (26%) with early recurrence and 45 patients (74%) with late recurrence or no recurrence. In a univariate analysis, lymph node metastases (P=0.0016), lymphatic invasion (P<0.0001), pancreatic invasion (P=0.0006), and perineural invasion (P=0.0004) were significantly different between the two groups. In a multivariate analysis, a higher incidence of lymphatic invasion was the only independent risk factor for early recurrence (odds ratio: 5.772, 95% confidence interval: 1.123–29.682, P=0.036). Moreover, the disease-free survival and overall survival of patients with a higher incidence of lymphatic invasion were significantly worse compared with those of patients with a lower incidence of lymphatic invasion (P<0.001). Conclusions. Our study showed that a higher incidence of lymphatic invasion was a significant predictor of early recurrence in patients with distal cholangiocarcinoma. Therefore, lymphatic invasion might be useful in determining the optimal adjuvant therapy in the early postoperative stage for distal cholangiocarcinoma.
机译:目的。确定胰腺癌切除术(PD)后远端胆管癌患者早期复发相关的因素。患者和方法。六十一名远端胆管癌患者注册。回顾性收集临床数据和组织病理学发现。结果。患者分为两组,如下:16名患者(26%)早期复发和45名患者(74%),复发晚期或不复发。在单变量分析中,淋巴结转移(P = 0.0016),淋巴侵入(P <0.0001),胰腺侵袭(P = 0.0006),两组之间的麻纹侵袭(P = 0.0004)显着差异。在多变量分析中,淋巴侵袭的较高发病率是早期复发的唯一独立危险因素(差距:5.772,95%:1.123-29.682,P = 0.036)。此外,与淋巴侵入发病率较低的患者相比,淋巴侵入发病率较高的患者的无疾病存活率和整体存活率显着恶化(P <0.001)。结论。我们的研究表明,淋巴侵入的发病率较高是远端胆管癌患者早期复发的重要预测因子。因此,淋巴侵袭可用于确定远端胆管癌早期术后阶段的最佳佐剂治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号